Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of targeted protein degradation therapies such as PROTACs (Proteolysis Targeting Chimeras). Its structure allows for effective linker functionality, connecting E3 ligase ligands to target protein binders. This enables the formation of ternary complexes that lead to the ubiquitination and subsequent degradation of disease-causing proteins. Also employed in bioconjugation due to the reactivity of the amino group, facilitating attachment to biomolecules for research and diagnostic applications. Its stability and solubility profile make it suitable for use in aqueous and organic reaction environments.